Trial intelligence / Profile preview

Liraglutide in Psoriatic Arthritis (PLAQUE)

NCT02472717Phase 2Withdrawn

Sponsor
University Health Network
Start
May 2015
Primary completion
Oct 2016
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of liraglutide in psoriatic arthritis (PsA), sponsored by University Health Network. Planned start May 2015; status: withdrawn.

02

Drugs

03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT02472717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02472717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call